Thousands of genes influence most diseases
In a provocative new perspective piece, Stanford researchers say that disease genes are spread uniformly across the genome, not clustered in specific molecular pathways, as has been thought.
A core assumption in the study of disease-causing genes has been that they are clustered in molecular pathways directly connected to the disease. But work by a group of researchers at the Stanford University School of Medicine suggests otherwise.
The gene activity of cells is so broadly networked that virtually any gene can influence disease, the researchers found. As a result, most of the heritability of diseases is due not to a handful of core genes, but to tiny contributions from vast numbers of peripheral genes that function outside disease pathways.
Any given trait, it seems, is not controlled by a small set of genes. Instead, nearly every gene in the genome influences everything about us. The effects may be tiny, but they add up.
The work is described in a paper published June 15 in Cell. Jonathan Pritchard, PhD, professor of genetics and of biology, is the senior author. Graduate student Evan Boyle and postdoctoral scholar Yang Li, PhD, share lead authorship.
The researchers call their provocative new understanding of disease genes an “omnigenic model” to indicate that almost any gene can influence diseases and other complex traits. In any cell, there might be 50 to 100 core genes with direct effects on a given trait, as well as easily another 10,000 peripheral genes that are expressed in the same cell with indirect effects on that trait, said Pritchard, who is also a Howard Hughes Medical Institute investigator.
Each of the peripheral genes has a small effect on the trait. But because those thousands of genes outnumber the core genes by orders of magnitude, most of the genetic variation related to diseases and other traits comes from the thousands of peripheral genes. So, ironically, the genes whose impact on disease is most indirect and small end up being responsible for most of the inheritance patterns of the disease.
“This is a compelling paper that presents a plausible and fascinating model to explain a number of confusing observations from genomewide studies of disease,” said Joe Pickrell, PhD, an investigator at the New York Genome Center, who was not involved in the work.
From a polygenic to omnigenic model
Until recently, said Pritchard, he thought of genetically complex traits as conforming to a polygenic model, in which each gene has a direct effect on a trait, whether that trait is something like height or a disease, such as autism.
The Latest on: Disease genes
- Rice engineers use gene editing to facilitate drug discovery based on natural funguson August 10, 2020 at 5:32 pm
Rice University scientists have won federal support for their pursuit of novel drugs to treat human disease. A five-year National Institutes of Health grant will allow the lab of biomolecular engineer ...
- Gene therapy to the inner retina prevents blindness in mouse model of CLN3 Batten diseaseon August 10, 2020 at 5:26 pm
Gene therapy to the inner retina prevented blindness in a mouse model of the neuro-degenerative disorder CLN3 Batten disease.
- Global Genetic Disease Diagnostic Market 2020 Report - Trends in Technological Strategies, Business Advancements and Top-Vendor Landscape to 2025on August 10, 2020 at 4:57 pm
Global Genetic Disease Diagnostic Market 2020 by Company, Regions, Type and Application, Forecast to 2025 published by MarketsandResearch.biz is an in-depth analysis of the global market size, ...
- Gene therapy targets inner retina to combat blindnesson August 10, 2020 at 1:20 pm
Batten disease is a group of fatal, inherited lysosomal storage disorders that predominantly affect children. The most prevalent form is CLN3 disease, for which there is no cure. Retinal degeneration ...
- Vast Underdiagnosis of Monogenic CV Disease Seen in Cath Referralson August 10, 2020 at 11:38 am
Most such patients with a heart-disease-linked gene variant and who showed clinical signs of the disease did not receive a diagnosis in a study said to support a broader role for genetic screening.
- Gene Therapy Market Trends Analysis, COVID-19 Impact, Key Players, Size Projection, Sales Statistics and Share Value By 2025on August 10, 2020 at 9:19 am
Gene Therapy Market Trends, Share and Size Analysis By Product (Kymriah, Luxturna, Yescarta, Zolgensma, Strimvelis, Zynteglo, Others), By Indication ...
- Stock Alert: Reata Pharmaceuticals Tanks 30% As Rare Genetic Disease Drug In Limboon August 10, 2020 at 7:43 am
(RTTNews) - Shares of Reata Pharmaceuticals Inc. (RETA) tanked nearly 30% on Monday morning after the drug maker's Omaveloxoloneon, a drug being developed to treat a rare neurodegenerative disorder, ...
- The CNIO pave the way for a future gene therapy to reverse pulmonary fibrosis associated with ageingon August 10, 2020 at 7:04 am
Our results indicate that a new therapy may be developed to prevent the development of pulmonary fibrosis associated with ageing,'' says CNIO's Maria Blasco, principal investigator of the study * Lung ...
- Global Cell and Gene Therapy Market, Forecast to 2025 by Product, Disease, End-user and Region - COVID-19 Updatedon August 10, 2020 at 2:15 am
The study considers the present scenario of the cell and gene therapy market and its market dynamics for the period 2019-2025. It covers a detailed overview of several market growth enablers, ...
- SOPHiA GENETICS' First Multimodal Approach to Predict COVID-19 Disease Evolutionon August 6, 2020 at 5:02 am
Driven Medicine, launches a first-of-its-kind multimodal solution to predict COVID-19 disease evolution, opening new dimensions of insight into the fight against the worldwide pandemic.
via Google News and Bing News